MIAMI, FL / ACCESSWIRE / April 6, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. PSUN, COOL, UNXL, and MSTX have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
Pacific Sunwear of California Inc. (NASDAQ: PSUN) has seen a rebound in price on Wednesday (4/6). Following a fall to lows of $0.0762 on Tuesday (4/5), shares of PSUN increased to highs of $0.138 on early Wednesday morning. This was an upswing of 81%. It has been reported from several media sources that the company may be expecting to file for bankruptcy.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here.
Majesco Entertainment Co. (NASDAQ: COOL) recently announced the launch of its new game, Glue, for PC. The stock has seen an increase in price of as much as 22 cents per share since late March. According to the company has spent significant time developing the game and it believes it will be a "great success in the market."
Subscribe Now And Reserve A Spot To Receive Our First Alert Of April. Get Your Free Membership Now.
Uni-Pixel, Inc. (NASDAQ: UNXL) announced on Wednesday (4/6) that it has been awarded two new 2-in-1 convertible programs from a leading PC manufacturing customer. 2-in-1 convertible computers combine the best features of a laptop and a tablet in one device. Jeff Hawthorne, president and chief executive officer of UniPixel, said, "We are pleased with the two design wins from this existing customer. Further orders from existing customers are an affirmation that not only does our technology resonate with customers, but our response time and service levels meet their requirements."
Shares of UNXL have seen an increase from a previous close of $0.92 to highs on Wednesday of $1.17 before 10:30AM EST. This represented an increase in price of more than 25%.
Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948.
Mast Therapeutics, Inc. (NYSE MKT: MSTX) announced that data from nonclinical studies of vepoloxamer, its lead product candidate, were presented at the American College of Cardiology 65th Annual Scientific Sessions & Expo. The company is developing two clinical-stage investigational new drugs for serious or life-threatening diseases and conditions. Since the end of March, the company’s stock has increased by 26.3% from lows of 0.2375 to highs of $0.30 on Wednesday 4/6.
Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here.
About TopNasdaqStocks.com
Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.
Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Pursuant to an agreement between us and a non affiliate 3rd party we were hired for a period beginning on 3/20/16 and ending on 6/19/16 to publicly disseminate information about (cool) including on the website and other media including facebook and twitter. We are being paid $100,000 (cash) for or were paid "zero" shares of unrestricted or restricted common shares. We own zero shares of (cool), which we purchased in the open market. We plan to sell the "zero" shares of (cool) that we hold during the time the website and/or facebook and twitter information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (cool) in the open market at any time, including before, during or after the website and information, provide public dissemination of favorable information. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding PSUN, UNXL, or MSTX in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.
Contact:
Top Nasdaq Stocks
news@topnasdaqstocks.com
SOURCE: Top Nasdaq Stocks
ReleaseID: 438505
